Gang Yin

Company: Sutro Biopharma

Job title: Executive Director

Seminars:

Leveraging Novel Expression Platforms & Precise Conjugation to Enable Immunostimulatory Antibody-Drug Conjugates (iADCs) 11:30 am

Providing an overview of Sutro’s proprietary cell-free expression system and site-specific conjugation technology Outlining the combination of an in vitro and in vivo platform to enable precise dual conjugation Assessing how combining ADC and immune agonists can potentially break tumor tolerance and elicit protective immunity in a single therapyRead more

day: Scientific Program Day One